Kit M, Kit S, Little S P, Di Marchi R D, Gale C
NovaGene Inc., Houston, TX.
Vaccine. 1991 Aug;9(8):564-72. doi: 10.1016/0264-410x(91)90243-y.
A recombinant infectious bovine rhinotracheitis virus (IBRV) vector has been constructed to express bovine growth hormone signal sequence plus a foot-and-mouth disease virus [FMDV (O1K)] capsid protein (VP1) epitope as the N-terminal sequence of an IBRV glycoprotein gIII fusion protein on the surface of virus infected cells and on the surface of virus particles. Sequences encoding the first 38 amino acids of IBRV gIII were deleted from the recombinant to avoid redundant glycoprotein signal sequences, but IBRV gIII epitopes detected by anti-gIII monoclonal antibodies were retained. Phenotypes were confirmed by in situ immunostaining of virus plaques with anti-FMDV peptide sera, by immunogold staining of permeabilized- and non-permeabilized infected cells, and by virus neutralization experiments with anti-FMDV peptide sera. Vaccination with the IBRV-FMDV recombinant induced protective levels of anti-FMDV antibodies in calves and protected them from challenge with virulent IBRV.
构建了一种重组传染性牛鼻气管炎病毒(IBRV)载体,以表达牛生长激素信号序列加口蹄疫病毒[FMDV(O1K)]衣壳蛋白(VP1)表位,作为病毒感染细胞表面和病毒颗粒表面上IBRV糖蛋白gIII融合蛋白的N端序列。从重组体中删除了编码IBRV gIII前38个氨基酸的序列,以避免多余的糖蛋白信号序列,但保留了抗gIII单克隆抗体检测到的IBRV gIII表位。通过用抗FMDV肽血清对病毒蚀斑进行原位免疫染色、对通透和未通透的感染细胞进行免疫金染色以及用抗FMDV肽血清进行病毒中和实验来确认表型。用IBRV-FMDV重组体进行疫苗接种可诱导犊牛产生具有保护水平的抗FMDV抗体,并保护它们免受强毒IBRV的攻击。